Ainos AAQS

Mitä Ainos tekee? Ainos Inc, a U.S.-based biotechnology company headquartered in San Diego, California, operates in the health care sector. The company, which went public on August 8, 1996, currently employs 43 full-time staff. Ainos Inc focuses on developing medical technologies for point-of-care testing and medical treatments across various disease indications. The company's research and development activities include securing intellectual property and commercializing therapeutics, particularly those utilizing low-dose non-injectable interferon (IFN). Among its product offerings are the COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, VELDONA (Very Low-Dose Oral Interferon Alpha), and Synthetic RNA (SRNA). The VOC POCT-Ainos Flora device is designed for non-invasive testing related to female vaginal health and certain sexually transmitted diseases. The VOC POCT-Ainos Pen is a portable, cloud-connected breath analyzer intended for health monitoring. The VOC POCT-CHS430 device aims to provide non-invasive testing for ventilator-associated pneumonia. Ainos Inc's website is www.ainos.com. The company's operational focus remains on advancing medical technologies for point-of-care applications. Ainos on yksi Eurpooliin suosituimmista yhtiöistä.